Skip to content
OpenCapital
Get started

Edgewise Therapeutics, Inc. EWTX Compensation and benefits

Compensation and benefits at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
——
Abbott logo
AbbottABT
——
Edwards Lifesciences logo
Edwards LifesciencesEW
——
Moderna logo
ModernaMRNA
——

Other financials

Income statement

See full
Operating income-$54.1M-17.7%
Net income-$49.0M-20.1%
EPS (diluted)-$0.46-7.0%

Balance sheet

See full
Cash & equivalents$33.2M-33.5%
Total debt$3.8M-16.8%
Total equity$493.2M+14.8%
Total assets$518.5M+14.1%

Cash flow

See full
Operating cash flow-$42.5M-12.4%
CapEx$260.0K+491%
Free cash flow-$42.8M-12.9%

Valuation

See full
Market cap$4.18B+61.3%

Returns & leverage

See full
Return on equity-38.1%+13.4pp
Debt / equity0×0.0×
Current ratio22.6×+1.6×

Where this comes from

Reported directly by Edgewise Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edgewise Therapeutics, Inc.'s compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Edgewise Therapeutics, Inc.'s compensation and benefits?
Edgewise Therapeutics, Inc. (EWTX) reported compensation and benefits of $5.68M in Q1 2026.
How has Edgewise Therapeutics, Inc.'s compensation and benefits changed year-over-year?
Edgewise Therapeutics, Inc.'s compensation and benefits increased by 42.9% year-over-year, from $3.97M to $5.68M.
What is the long-term trend for Edgewise Therapeutics, Inc.'s compensation and benefits?
Over 5 years (2020 to 2025), Edgewise Therapeutics, Inc.'s compensation and benefits has grown at a 60.3% compound annual growth rate (CAGR), from $1.18M to $12.43M.